[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"low-protein-dietary-intake\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:low-protein-dietary-intake":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100584661","suitability-of-two-flavours-of-a-high-energy-low-protein-formula-renalive-lp-in-chronic-kidney-disease-stage-3b-5-outpatients-in-taiwan-100584661",false,"NCT06892249","Suitability of a High-energy, Low-protein Formula (Renalive® LP)","Inclusion Criteria:\n\n(1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\\\u003C45 mL\u002Fmin\u002F1.73 m2)\n\nExclusion Criteria:\n\n(1) Has received dialysis or are expected to start dialysis within the next 3 months","ALL","18 Years",{"count":18,"type":19},80,"ESTIMATED","INTERVENTIONAL",[22],"NA","Inclusion criteria (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\\\u003C45 mL\u002Fmin\u002F1.73 m2)\n\nExclusion criteria\n\n(1) Has received dialysis or are expected to start dialysis within the next 3 months.",[25,26,27],"CKD","Low Protein Dietary Intake","Malnutrition (Calorie)","RECRUITING","2026-09-30",{"date":31,"type":32},"2026-10-01","ACTUAL",{"date":34,"type":32},"2025-06-04",{"date":36,"type":19},"2027-12-31",{"name":38,"class":39},"Fresenius Kabi Taiwan Ltd.","INDUSTRY",2]